Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from China
- PMID: 35528983
- PMCID: PMC9039709
- DOI: 10.14218/JCTH.2021.00082
Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from China
Abstract
Background and aims: Chronic kidney disease (CKD) usually occurs during the chronic infection of hepatitis B virus (HBV). However, the risk factors of CKD in an HBV population have not been completely demonstrated. Our present study aimed to investigate the risk factors of CKD in chronic HBV infection using a hospital based cross-sectional study in the northern area of China.
Methods: During January 2013 to December 2017, a total of 94 patients with CKD complicated by chronic HBV infection were consecutively enrolled in the study, as well as 548 age- and sex-matched hepatitis B patients without CKD who were enrolled as controls. Univariate and multivariate regression analyses were used to determine the effects of each variable after adjusting for cofounding factors.
Results: Multivariate analysis showed that HBeAg-positive status (odds ratio [OR]=2.099, 95% CI 1.128-3.907), dyslipidemia (OR: 3.025, 95% CI 1.747-5.239), and hypertension (OR: 12.523, 95% CI 6.283-24.958) were independently associated with the incidence of CKD, while duration of HBV infection (≥240 months) (OR: 0.401, 95% CI 0.179-0.894), Log10 HBsAg (OR: 0.514, 95% CI 0.336-0.786), and coronary heart disease (OR: 0.078, 95% CI 0.008-0.768) were protective factors for the incidence of CKD. Duration of HBV infection, Log10 HBsAg, HBeAg-positive status and dyslipidemia remained the risk factors for CKD after adjusting for diabetes mellitus, hypertension, and coronary heart disease.
Conclusions: Duration of HBV infection, Log10 HBsAg, HBeAg-positive status and dyslipidemia contributed to the incidence of CKD during chronic HBV infection in a Chinese population.
Keywords: Case-control study; Chronic kidney disease; Cross-sectional study; Hepatitis B virus; Risk factors.
© 2022 Authors.
Conflict of interest statement
YCF has been an associate editor of Journal of Clinical and Translational Hepatology since 2013.The other authors have no conflicts of interest related to this publication.
Figures
Similar articles
-
Chronic hepatitis B virus infection and risk of chronic kidney disease: a population-based prospective cohort study of 0.5 million Chinese adults.BMC Med. 2018 Jun 18;16(1):93. doi: 10.1186/s12916-018-1084-9. BMC Med. 2018. PMID: 29909773 Free PMC article.
-
Association between hepatitis B virus infection and chronic kidney disease: A cross-sectional study from 3 million population aged 20 to 49 years in rural China.Medicine (Baltimore). 2019 Feb;98(5):e14262. doi: 10.1097/MD.0000000000014262. Medicine (Baltimore). 2019. PMID: 30702585 Free PMC article.
-
A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.Int J Epidemiol. 1998 Aug;27(4):574-8. doi: 10.1093/ije/27.4.574. Int J Epidemiol. 1998. PMID: 9758109
-
HBV infection is a risk factor for chronic kidney disease: Systematic review and meta-analysis.Rev Clin Esp. 2020 Feb 6:S0014-2565(19)30325-X. doi: 10.1016/j.rce.2019.10.010. Online ahead of print. Rev Clin Esp. 2020. PMID: 32037008 Review. English, Spanish.
-
Chronic hepatitis B virus infection in Asian countries.J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. doi: 10.1046/j.1440-1746.2000.0150121356.x. J Gastroenterol Hepatol. 2000. PMID: 11197043 Review.
Cited by
-
Hepatitis B virus infection as a risk factor for chronic kidney disease: a systematic review and meta-analysis.BMC Infect Dis. 2024 Jun 22;24(1):620. doi: 10.1186/s12879-024-09546-z. BMC Infect Dis. 2024. PMID: 38909191 Free PMC article.
-
Screening for renal impairment in viral hepatopathy B: it is time to begin.Future Sci OA. 2023 Jul 6;9(9):FSO886. doi: 10.2144/fsoa-2023-0019. eCollection 2023 Oct. Future Sci OA. 2023. PMID: 37752918 Free PMC article.
-
Liver fibrosis MR images classification based on higher-order interaction and sample distribution rebalancing.Health Inf Sci Syst. 2023 Nov 8;11(1):51. doi: 10.1007/s13755-023-00255-6. eCollection 2023 Dec. Health Inf Sci Syst. 2023. PMID: 37954065 Free PMC article.
-
Targeting hepatitis B virus-associated nephropathy: efficacy and challenges of current antiviral treatments.Clin Exp Med. 2025 Feb 15;25(1):57. doi: 10.1007/s10238-025-01584-4. Clin Exp Med. 2025. PMID: 39954162 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources